4//SEC Filing
Ni Fang 4
Accession 0001415889-22-012966
CIK 0001701541other
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 4:23 PM ET
Size
7.2 KB
Accession
0001415889-22-012966
Insider Transaction Report
Form 4
Ni Fang
See Remarks
Transactions
- Purchase
Common Stock
2022-12-21$1.29/sh+20,000$25,770→ 89,026 total - Purchase
Common Stock
2022-12-22$1.28/sh+36,363$46,596→ 125,389 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.27 to $1.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.23 to $1.3099, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Documents
Issuer
Black Diamond Therapeutics, Inc.
CIK 0001701541
Entity typeother
Related Parties
1- filerCIK 0001895910
Filing Metadata
- Form type
- 4
- Filed
- Dec 22, 7:00 PM ET
- Accepted
- Dec 23, 4:23 PM ET
- Size
- 7.2 KB